stockrowKrystal Biotech, Inc. (KRYS) vs Madrigal Pharmaceuticals, Inc. (MDGL)
- Krystal Biotech, Inc. KRYS 300.31 +0.02%
- Madrigal Pharmaceuticals, Inc. MDGL 397.03 −0.77%
Krystal Biotech, Inc. and Madrigal Pharmaceuticals, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and Madrigal Pharmaceuticals, Inc. are of similar size ($9.3B and $8.9B). Madrigal Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 92.8% against 26.0%. Krystal Biotech, Inc. has the higher net margin (47.9% vs −10.9%) and the higher return on invested capital (27.2% vs −1,480.3%). Across the 17 metrics below, Krystal Biotech, Inc. leads on 14 and Madrigal Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | KRYS | MDGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.27% | 90.96% | 65.16% |
| Operating margin | 48.41% | (10.69%) | 0.00% |
| Net margin | 47.91% | (10.89%) | 0.00% |
| Free cash flow margin | 65.97% | (11.81%) | 0.00% |
| Return on equity | 17.50% | (24.82%) | (50.12%) |
| Return on assets | 15.93% | (11.12%) | (45.60%) |
| Return on invested capital | 27.15% | (1,480.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack